Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ISRCTN10343007) titled 'Deferred registration - ICON Clinical (UK) Limited/Newcastle Upon Tyne Hospitals NHS Foundation Trust Code: BP45361' on Oct. 5.
Study Type: Interventional
Study Design:
Allocation: N/A: single arm study
Masking: Open (masking not used)
Control: Uncontrolled
Assignment: Single
Purpose: Phase I trial examining safety, tolerability, pharmacokinetics, and pharmacodynamics
Primary Sponsor: F. Hoffman-La Roche AG
Condition:
The Health Research Authority has approved a deferral. Full details will be added to the trial record on or before the deferral expiry date.
Other
Intervention:
The Health Research Authority ha...